跳转至内容
Merck
  • Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.

Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.

Antimicrobial agents and chemotherapy (2008-06-04)
Amélie Carrër, Laurent Poirel, Haluk Eraksoy, A Atahan Cagatay, Selim Badur, Patrice Nordmann
摘要

The first outbreak of carbapenem-resistant Klebsiella pneumoniae isolates producing the plasmid-encoded carbapenem-hydrolyzing oxacillinase OXA-48 is reported. The 39 isolates belonged to two different clones and were collected at the University Hospital of Istanbul, Turkey, from May 2006 to February 2007, and they coproduced various beta-lactamases (SHV-12, OXA-9, and TEM-1 for clone A and CTX-M-15, TEM-1, and OXA-1 for clone B).

材料
货号
品牌
产品描述

Sigma-Aldrich
甲氧苄啶, ≥98.5%
Sigma-Aldrich
阿莫西林, 95.0-102.0% anhydrous basis
Sigma-Aldrich
四环素, 98.0-102.0% (HPLC)
Sigma-Aldrich
甲氧苄啶, ≥99.0% (HPLC)
Sigma-Aldrich
氧氟沙星, fluoroquinolone antibiotic
Sigma-Aldrich
环丙沙星, ≥98% (HPLC)
Sigma-Aldrich
萘啶酸, ≥98%
Supelco
诺氟沙星, analytical standard, ≥98% (TLC)
Supelco
甲氧苄啶, VETRANAL®, analytical standard
Supelco
氧氟沙星, VETRANAL®, analytical standard
Supelco
诺氟沙星, VETRANAL®, analytical standard